» Articles » PMID: 19543322

A Combinatorial Mechanism for Determining the Specificity of E2F Activation and Repression

Overview
Journal Oncogene
Date 2009 Jun 23
PMID 19543322
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Various studies have detailed the role of E2F proteins in both transcription activation and repression. Further study has shown that distinct promoter elements, but comprising the same E2F-recognition motif, confer positive or negative E2F control and that this reflects binding of either activator or repressor E2F proteins, respectively. We now show that the specificity of binding of an activator or repressor E2F protein is determined by adjacent sequences that bind a cooperating transcription factor. We propose that the functional E2F element is a module comprising not only the E2F-binding site but also the adjacent site for the cooperating transcription factor.

Citing Articles

Insight into mammary gland development and tumor progression in an E2F5 conditional knockout mouse model.

To B, Broeker C, Jhan J, Garcia-Lerena J, Vusich J, Rempel R Oncogene. 2024; 43(46):3402-3415.

PMID: 39341991 PMC: 11554565. DOI: 10.1038/s41388-024-03172-4.


Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.

Shang Y, Zhang Y, Liu J, Chen L, Yang X, Zhu Z J Cancer. 2022; 13(2):653-668.

PMID: 35069909 PMC: 8771517. DOI: 10.7150/jca.61415.


E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.

Mustafa N, Mitxelena J, Infante A, Zenarruzabeitia O, Eriz A, Iglesias-Ara A Int J Mol Sci. 2022; 23(1).

PMID: 35008734 PMC: 8745065. DOI: 10.3390/ijms23010311.


Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients.

Sacconi A, De Vitis C, de Latouliere L, Di Martino S, De Nicola F, Goeman F Cell Death Dis. 2021; 12(11):1019.

PMID: 34716309 PMC: 8553595. DOI: 10.1038/s41419-021-04299-y.


Long Noncoding RNA Promotes Progression and Predicts Patient Prognosis in Human Ovarian Cancer.

Park S, Kim L, Kim Y, Heo T, Kim H Cancers (Basel). 2020; 12(12).

PMID: 33287341 PMC: 7761684. DOI: 10.3390/cancers12123626.


References
1.
Wysocka J, Herr W . The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem Sci. 2003; 28(6):294-304. DOI: 10.1016/S0968-0004(03)00088-4. View

2.
DeGregori J, Johnson D . Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. Curr Mol Med. 2006; 6(7):739-48. DOI: 10.2174/1566524010606070739. View

3.
Matys V, Kel-Margoulis O, Fricke E, Liebich I, Land S, Barre-Dirrie A . TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 2005; 34(Database issue):D108-10. PMC: 1347505. DOI: 10.1093/nar/gkj143. View

4.
Lissy N, Davis P, Irwin M, Kaelin W, Dowdy S . A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature. 2000; 407(6804):642-5. DOI: 10.1038/35036608. View

5.
Kong L, Chang J, Bild A, Nevins J . Compensation and specificity of function within the E2F family. Oncogene. 2006; 26(3):321-7. DOI: 10.1038/sj.onc.1209817. View